BR
Bhimrao Ramrao Jaiwal
About Bhimrao Ramrao Jaiwal
Data last updated:
Bhimrao Ramrao Jaiwal was a Director at Kings Global Biotech Limited (2016–2022) and Director at Skp Global Medicines Private Limited (2016–2022). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kings Global Biotech Limited U33119PN2016PLC164905 | Director | 09 Jun 2016 | 2016 | ₹50.04 Cr (FY 2024) | Active |
 Skp Global Medicines Private Limited U33100PN2016PTC166968 | Director | 28 Oct 2016 | 2016 | ₹10.96 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhimrao Ramrao Jaiwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhimrao Ramrao Jaiwal
Bhimrao Ramrao Jaiwal was first appointed on 09 Jun 2016 as Director at Kings Global Biotech Limited.
Bhimrao Ramrao Jaiwal held 2 earlier board appointments: Kings Global Biotech Limited (Director, 09 Jun 2016 to 30 Sep 2022); Skp Global Medicines Private Limited (Director, 28 Oct 2016 to 30 Sep 2022).